In November 2024, Montmorillonite Powder (specification: each sachet contains 3g of montmorillonite), independently researched, developed and manufactured by Zhejiang Asen Pharmaceutical Co., Ltd., was approved by the National Medical Products Administration (NMPA) (Drug Approval Number: Guo Yao Zhu...

In June 2023, Zhejiang Asen Pharmaceutical Co., Ltd. received the "Supplemental Drug Application Approval Notice" (Notice No.: 2023B03185) for Ornidazole Tablets from the National Medical Products Administration (NMPA). This marks another product of the company to successfully pass the Con...

In July 2022, Zhejiang Asen Pharmaceutical Co., Ltd. received the Supplemental Drug Application Approval Notice (Notice No.: 2022B03068) for Progesterone Soft Capsules issued by the National Medical Products Administration (NMPA), marking the product as the first in China to pass the Consistency Eva...